Simcere Sells Celgen Stake for $49 Million
Simcere Pharma has sold its 35% stake in Shanghai Celgen Bio-Pharmaceutical for 302 million RMB ($48.6 million). That’s more than twice the $20.6 million Simcere paid for the shares in 2009. Celgen makes a biosimilar version of arthritis treatm..
Original Article: Simcere Sells Celgen Stake for $49 MillionNEXT ARTICLE